LBPWQ (4d pharma) FCF Margin %: -3,584.20% (As of Dec. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LBPWQ 4d pharma PLC LBPWQ
34 GF Score
Price $0.00
! 9 Warning Signs
View Full Analysis

What is 4d pharma FCF Margin %?

4d pharma LBPWQ 34 FCF Margin % is -3,584.20% as of Dec. 2021. GuruFocus rates LBPWQ with a GF Score™ of 34/100. The stock has 9 warning signs investors should review.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. 4d pharma's Free Cash Flow for the six months ended in Dec. 2021 was $-13.84 Mil. 4d pharma's Revenue for the six months ended in Dec. 2021 was $0.39 Mil. Therefore, 4d pharma's FCF Margin % for the quarter that ended in Dec. 2021 was -3,584.20%.

As of today, 4d pharma's current FCF Yield % is -3,580,900.00%.

The historical rank and industry rank for 4d pharma's FCF Margin % or its related term are showing as below:


LBPWQ's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -76.29
* Ranked among companies with meaningful FCF Margin % only.

4d pharma FCF Margin % Related Terms

4d pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for 4d pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4d pharma FCF Margin % Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -10,938.66 -4,277.58 -4,844.96

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,500.37 -5,130.81 -3,379.02 -6,421.85 -3,584.20

LBPWQ vs REGN, VRTX, MRNA: FCF Margin % Comparison

For the Biotechnology subindustry, 4d pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4d pharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where 4d pharma's FCF Margin % falls into.


LBPWQ
34GF Score
4d pharma PLC LBPWQ
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4d pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

4d pharma's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-33.624/0.694
=-4,844.96 %

4d pharma's FCF Margin for the quarter that ended in Dec. 2021 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2021 )/Revenue (Q: Dec. 2021 )
=-13.835/0.386
=-3,584.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -3,584.20% mean?
4d pharma (LBPWQ) has a FCF Margin % of -3,584.20% as of Dec. 2021. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 4d pharma and its competitors.
Is 4d pharma's FCF Margin % too high?
4d pharma's current FCF Margin % is -3,584.20%. Overall, 4d pharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does 4d pharma's FCF Margin % compare to REGN and VRTX?
4d pharma's FCF Margin % of -3,584.20% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 4d pharma and its competitors. 4d pharma's current FCF Margin % is -3,584.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4d pharma stock overvalued right now?
4d pharma (LBPWQ) has a current FCF Margin % of -3,584.20%. The current FCF Margin % is -3,584.20%. 4d pharma's overall GF Score™ is 34/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For 4d pharma (LBPWQ), the current FCF Margin % is -3,584.20% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

4d pharma Business Description

Address 9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.
34GF Score

Get the complete analysis for LBPWQ

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price